Chloe Botaine

Chloe Botaine

Biopharmaceutical Research Specialist
Chloe Botaine specializes in biopharmaceutical research and development, offering insights into the latest trends, challenges, and breakthroughs in biopharma. Her content covers topics such as drug discovery, clinical trials, and regulatory affairs. With a focus on advancing science and improving patient care, Chloe’s content contributes to the development of innovative therapies and medicines that address unmet medical needs and improve public health outcomes.
Are Montana's New Rules Truly Closing Gaps in Hospital Oversight?
Management & Regulatory Are Montana's New Rules Truly Closing Gaps in Hospital Oversight?

In an effort to crack down on perceived inadequacies in the oversight of nonprofit hospitals’ charitable activities, the state of Montana has rolled out new rules aimed at closing long-standing gaps. This move stems from a legislative audit conducted more than four years ago, which critiqued the o

Can High-Fructose Corn Syrup Fuel Cancer Growth and Spread?
Research & Development Can High-Fructose Corn Syrup Fuel Cancer Growth and Spread?

The relationship between dietary fructose, particularly from high-fructose corn syrup, and cancer growth is a topic of growing concern. Over the past few decades, the consumption of high-fructose corn syrup has skyrocketed. While naturally occurring fructose in fruits, vegetables, and honey is

Repurposed Drug Selinexor Shows Promise for Treating KRAS Mutant NSCLC
Research & Development Repurposed Drug Selinexor Shows Promise for Treating KRAS Mutant NSCLC

Recent advances in the fight against non-small cell lung cancer (NSCLC) have brought new hope for patients carrying KRAS mutations, thanks to a breakthrough discovery by researchers at UT Southwestern Harold C. Simmons Comprehensive Cancer Center. This advancement revolves around the repurposing of

New Study Reveals Brain-Body Immune System Communication Hubs
Research & Development New Study Reveals Brain-Body Immune System Communication Hubs

Researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London have made a groundbreaking discovery that challenges the traditional understanding of the immune system's operation. Their study, published in the journal Brain, reveals crucial

Optimizing Clinical Trials with Technology and Private Equity Support
Research & Development Optimizing Clinical Trials with Technology and Private Equity Support

The pharmaceutical industry is currently experiencing a transformative period marked by evolving clinical trial dynamics, increased R&D investment, and significant post-pandemic adjustments. This transformation is primarily driven by the complexities of modern trials, the demands for

Are Genetic Factors Increasing Prostate Cancer Risk for African Men?
Research & Development Are Genetic Factors Increasing Prostate Cancer Risk for African Men?

Prostate cancer has become an alarming health issue, particularly among African men, who are increasingly found to be at higher risk compared to men of other ethnicities. Various studies point towards genetic factors playing a significant role in this elevated risk, coupled with inadequate

Do Certain E. Coli Strains Increase Cancer Risk in Developed Countries?
Research & Development Do Certain E. Coli Strains Increase Cancer Risk in Developed Countries?

Scientists have long sought to understand the various factors that contribute to the prevalence of cancer, and recent research has shed light on a surprising potential culprit: Escherichia coli (E. coli). A study conducted by researchers from the Wellcome Sanger Institute and the University of

Can We Eliminate Cervical Cancer in the UK by 2040?
Research & Development Can We Eliminate Cervical Cancer in the UK by 2040?

Cervical cancer, despite being largely preventable, continues to claim the lives of two women in the UK every day—a stark reminder of the ongoing battle against the disease. In a bid to change this grim statistic, NHS England has committed to an ambitious goal of eliminating cervical cancer by 2

Can We Control Single-Molecule Reactions for Better Drug Synthesis?
Tech & Innovation Can We Control Single-Molecule Reactions for Better Drug Synthesis?

The ability to control matter at the atomic level with remarkable precision has long been a dream in the field of nanotechnology. Recent advancements led by physicists at the University of Bath, in collaboration with an international team, have brought us closer to this goal. This breakthrough

Can Cell Therapy Revolutionize Treatment for Severe Viral Infections?
Research & Development Can Cell Therapy Revolutionize Treatment for Severe Viral Infections?

In a groundbreaking development, QIMR Berghofer has made significant strides in combating severe viral infections in immunocompromised patients through their pioneering cell therapy. This innovative treatment has proven effective in 46 out of 71 patients, resulting in a notable 65% success rate.

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later